尊龙凯时ag官方入口

The World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) are strengthening their cooperation and practical coordination on issues around public health, intellectual property (IP) and trade.

The three organizations meet regularly, exchange information on their respective work programs and discuss and plan, within the possibilities of their respective mandates and budgets, common activities. The trilateral cooperation is intended to contribute to enhancing the empirical and factual information basis for policy makers and supporting them in addressing public health in relation to IP and trade.

The WHO Global Strategy and Plan of Action on Public Health, Innovation and IP, the WIPO Development Agenda and the WTO Declaration on the TRIPS agreement and public health, provide the broader context for an informal and practical trilateral cooperation at the working level.

Contact us

Trilateral_Workshop-845x475

尊龙凯时ag老虎机

A one-stop shop for the full range of WHO, WIPO and WTO expertise at the interface of public health, IP and trade matters.

Featured

trilateral-20231114-845
(Image: Emmanuel Berrod)

尊龙凯时ag老虎机

On 14 November, 2023, the World Health Organization (WHO), WIPO and the World Trade Organization (WTO) held the 10 th  Joint Technical Symposium titled “Facing the Future: Human Health and Climate Change”. The event underscored the importance of exploring the intersections between public health, trade, and intellectual property (IP) to leverage existing tools, and develop new technologies, to address the effects of climate change on human health, especially among the world’s most marginalized populations.

Featured

尊龙凯时官网入口最新网址

The coronavirus disease 2019 (COVID-19) pandemic constitutes an extraordinary global public health crisis that has created a pressing need for intensified global cooperation. This updated information note maps the myriad challenges posed by the outbreak in relation to the integrated health, trade and IP policy frameworks. It provides cross-references to the relevant sections in the updated trilateral study. The text is available in English.

The text of the first update (from August 2021) is available in Arabic, Chinese, English, French, Russian , and Spanish .

尊龙凯时ag网页版

尊龙凯时官网入口注册网站

Medical technologies – medicines, vaccines and medical devices – are essential for public health. Access to essential medicines and the lack of research to address neglected diseases have been a major concern for many years. To promote innovation and to ensure equitable access to all vital medical technologies, policy-makers need a clear understanding of the innovation processes that lead to new technologies and of the ways in which these technologies are disseminated in health systems. This study seeks to reinforce the understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and of how they affect medical innovation and access to medical technologies.

The second edition comprehensively reviews the existing material and captures new developments in key areas since the initial launch of the study in 2013. Among the new topics covered by the study are antimicrobial resistance and cutting-edge health technologies. The second edition provides updated data on health, innovation trends in the pharmaceutical sector, and trade and tariffs. It includes an updated overview of access to medical technologies globally and key provisions in free trade agreements, and takes account of developments in IP legislation and jurisprudence.

A collaborative effort by WHO, WIPO and WTO, this study draws together the three Secretariats’ respective areas of expertise.  It is intended to inform ongoing technical cooperation activities undertaken by the three organizations and to support policy discussions.

Based on many years of field experience in technical cooperation, the study has been prepared to serve the needs of policy-makers who seek a comprehensive presentation of the full range of issues, as well as lawmakers, government officials, delegates to international organizations, non-governmental organizations and researchers.

The second edition of the study is available in Arabic , Chinese ,  English, French , Spanish and Russian.

The first edition of the study is available in , , English, French, Russian and Spanish.

Meetings and documents